Application of solid-phase microextraction in the investigation of protein binding of pharmaceuticals.
Protein-drug interactions of seven common pharmaceuticals were studied using solid-phase microextraction (SPME). SPME can be used in such investigations on the condition that no analyte depletion occurs. In multi-compartment systems (e.g. a proteinaceous matrix) only the free portion of the analyte is able to partition into the SPME fiber. In addition if no sample depletion occurs, the bound drug-free drug equilibria are not disturbed. In the present study seven pharmaceuticals (quinine, quinidine, naproxen, ciprofloxacin, haloperidol, paclitaxel and nortriptyline) were assayed by SPME. For quantitative purposes SPME was validated first in the absence of proteins. Calibration curves were constructed for each drug by HPLC-fluorescence and HPLC-UV analysis. SPME was combined to HPLC off-line, desorption occurring in HPLC inserts filled with 200 microL methanol. Binding of each drug to human serum albumin was studied independently. Experimental results were in agreement with literature data and ultrafiltration experiments, indicating the feasibility of the method for such bioanalytical purposes.
Theodoridis
Georgios
G
Laboratory of Analytical Chemistry, Department of Chemistry, Aristotle University Thessaloniki, 541 24 Thessaloniki, Greece. gtheodor@chem.auth.gr
D001667:Binding, Competitive; D002851:Chromatography, High Pressure Liquid / Q000379:methods*; D002939:Ciprofloxacin / Q000378:metabolism; D006220:Haloperidol / Q000378:metabolism; D006801:Humans; D007700:Kinetics; D009288:Naproxen / Q000378:metabolism; D009661:Nortriptyline / Q000378:metabolism; D017239:Paclitaxel / Q000378:metabolism; D004364:Pharmaceutical Preparations / Q000378:metabolism*; D011485:Protein Binding; D011802:Quinidine / Q000378:metabolism; D011803:Quinine / Q000378:metabolism; D012709:Serum Albumin / Q000378:metabolism*; D013050:Spectrometry, Fluorescence / Q000379:methods; D013056:Spectrophotometry, Ultraviolet / Q000379:methods; D014462:Ultrafiltration / Q000379:methods
D004364:Pharmaceutical Preparations; D012709:Serum Albumin; D009288:Naproxen; D002939:Ciprofloxacin; D011803:Quinine; D009661:Nortriptyline; D011802:Quinidine; D006220:Haloperidol; D017239:Paclitaxel